SKYE
SKYE
NASDAQ · Biotechnology

Skye Bioscience Inc

$0.58
-0.04 (-6.63%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 11 79%
Hold 3 21%
Sell 0 0%
Price Target
Analyst Price Target +2,655.6% upside
Low Target $11.92
Average Target $15.90
High Target $19.90
Current Price $0.58
Current
$0.58
Target
$15.90
$11.92 $15.90 avg $19.90
Scenario Analysis
Bear Case
$11.92
1,965.9%
Low target
Base Case
$15.90
+2,655.6%
Avg target
Bull Case
$19.90
+3,348.9%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$5.75
-90.0% from high
52-Week Low
$0.60
+-3.8% from low
Target vs 52W High
$15.90
+176.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%